HER2 positive breast cancer and its treatment with trastuzumab, where are we now?. Bioengineering Studies [Internet]. 2022 Dec. 30 [cited 2026 Jul. 2];3(2):35-43. Available from: https://journals.ardascience.com/index.php/bes/article/view/239